Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
431-02-002 / 431-02-002 ISMRM Abstract

CEST vs. DWI vs. FDG-PET/CT vs. Combined Index Method: Prediction Capability for Patient’s Outcome in Stage I NSCLC Patients

Primary: Body - Lung
Secondary: Contrast Mechanisms - CEST / APT / NOE
431-02-002 · A Clearer View Within: Advances in Body Imaging · Tuesday, 12 May, 1:40 PM–3:16 PM · Roof Terrace
431-02-002 · A Clearer View Within: Advances in Body Imaging · Tuesday, 12 May, 1:40 PM–3:16 PM · Roof Terrace
Keywords: Cancer CEST / APT / NOE Lung Neoplasm Recurrence Diffusion-Weighted Imaging
Accepted
Masahiro Endo1,2, Natsuka Yazawa3, Kaori Yamamoto3, Yuichiro Sano3, Masato Ikedo3, Masanori Ozaki3, Masao Yui3, Takahiro Ueda2, Masahiko Nomura2,4, Takeshi Yoshikawa2,5, Daisuke Takenaka2,6, Yoshiyuki Ozawa2, Yoshiharu Ohno 2,4
1Diagnostic Radiology, Shizuoka Cancer Center, Sunto-gun, Japan
2Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan
3Canon Medical Systems Corporation, Otawara-shi, Japan
4Joint Research Laboratory of Advanced Medical Imaging & Artificial Intelligence, Fujita Health University School of Medicine, Toyoake, Japan
5Radiology, Fujita Health University Bantane Hospital, Nagoya, Japan
6Radiology, Fujita Health University Okazaki Medical Center, Okazaki, Japan
Presenting Author: Yoshiharu Ohno

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Filho AM, Laversanne M, Ferlay J, et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336-1346.
2. Ohno Y, Yui M, Koyama H, et al. Chemical Exchange Saturation Transfer MR Imaging: Preliminary Results for Differentiation of Malignant and Benign Thoracic Lesions. Radiology. 2016 May;279(2):578-89.
3. Ohno Y, Kishida Y, Seki S, et al. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT. J Magn Reson Imaging. 2018 Apr;47(4):1013-1021.
4. Ohno Y, Yui M, Yamamoto K, et al. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients. J Magn Reson Imaging. 2023 Jul;58(1):174-186.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/431-02-002